Cullinan Oncology Inc. (CGEM)

8.00

-0.49 (-5.77%)

At close: Mar 03, 2025, 3:59 PM

8.00

0.00%

After-hours: Mar 03, 2025, 04:00 PM EST

Cullinan Oncology Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-167.57M	-153.16M	109.19M	-67.48M	-59.46M	-21.65M	-14.19M
Depreciation & Amortization	306K	310K	93K	53K	62K	70K	43K
Stock-Based Compensation	37.82M	30.44M	27.96M	24.38M	14.91M	17K	n/a
Other Working Capital	n/a	-172K	11.69M	1.29M	1.27M	-504K	120K
Other Non-Cash Items	-15.86M	-11.52M	-275.08M	67K	7.63M	539K	252K
Deferred Income Tax	n/a	n/a	n/a	3.1M	233K	-4K	n/a
Change in Working Capital	n/a	-339K	11.18M	-3.54M	6.85M	135K	345K
Operating Cash Flow	-145.3M	-134.28M	-126.66M	-43.43M	-29.77M	-20.9M	-13.55M
Capital Expenditures	n/a	-208K	-1.13M	-589.23K	-10K	-20K	-261K
Acquisitions	n/a	-36.01K	275M	923K	1.45M	n/a	n/a
Purchase of Investments	-721.13M	-373.38M	-377.92M	-525.81M	-69.76M	-35.38M	n/a
Sales Maturities Of Investments	584.82M	409.4M	352.93M	192.04M	62.9M	n/a	n/a
Other Investing Acitivies	n/a	36.01K	91K	-333.77K	-5.41K	-35.38K	n/a
Investing Cash Flow	-136.31M	35.81M	248.97M	-333.77M	-5.42M	-35.4M	-261K
Debt Repayment	n/a	1.82M	-2.2M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-378K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	266.19M	538K	-23.73M	1.52M	138.88M	85.72M	-30K
Financial Cash Flow	266.19M	40.75M	-25.93M	268.78M	140.14M	85.72M	-29K
Net Cash Flow	-15.43M	-57.72M	96.38M	-108.42M	104.95M	29.42M	-13.84M
Free Cash Flow	-145.3M	-134.48M	-127.8M	-44.02M	-29.78M	-20.92M	-13.81M